1.Review of gallium-based liquid metals for medical applications
Pei-Kai ZHAO ; Yu-Long WANG ; Yong-Kang ZHAN ; Jia-Xing QI ; Xu-Yi CHEN
Chinese Medical Equipment Journal 2024;45(11):97-102
The gallium-based liquid metals were introduced in terms of the advantages when applied in medical field,application status in medical imaging,drug delivery,antibiosis and tumor therapy and cutting-edge application in flexible e-skin,wearable sensor and flexible medical device.The deficiencies of the gallium-based liquid metals in durability,potential toxicity,high cost of preparation and difficulty of process control were analyzed when applied in medical fields.The future development directions of the gallium-based liquid metals were pointed out.[Chinese Medical Equipment Journal,2024,45(11):97-102]
2.Advances in the research of HIV-1 envelope glycoprotein gp120 inhibitors
Ming-hui XIE ; Zhao WANG ; Yan-ying SUN ; Xiang-yi JIANG ; Peng ZHAN ; Xin-yong LIU ; Dong-wei KANG
Acta Pharmaceutica Sinica 2023;58(3):616-628
From the process of human immunodeficiency virus-1 (HIV-1) invading cells, the combination of gp120 and CD4 is the first step for HIV-1 to invade cells. Interfering with this process can prevent HIV from recognizing target cells and inhibit virus replication. Therefore, HIV-1 gp120 is an important part of the HIV-1 life cycle. Fostesavir, a phosphatate prodrug derived from the gp120 inhibitor BMS-626529 modified by the prodrug strategy, was approved for the treatment of adult patients with multidrug resistant HIV-1 infection by the US FDA and the European Medicines Agency in 2020 and 2021, respectively. In this review, we focus on the research progress of small molecule inhibitors targeting the interaction of gp120-CD4 from the perspective of medicinal chemistry, in order to provide reference for the subsequent research of gp120 inhibitors.
3.Design of intelligent positioning system for mobile medical equipment in operating room based on Bluetooth technology
Zhi-Meng LIU ; Ya-Dong LYU ; Long-Xue QIAO ; Lin-Huai TIAN ; Kun YANG ; Kai-Yuan LI ; Ning-Bo ZHAN ; Ying-Kang WEI ; Yong CHAO
Chinese Medical Equipment Journal 2023;44(9):29-32
Objective To develop an intelligent positioning system for mobile medical equipment in the operating room based on Bluetooth technology to enhance medical equipment management efficiency.Methods The intelligent positioning system for mobile medical equipment used received signal strength indication(RSSI)algorithm and multi-gateway trajectory filtering algorithm to realize Bluetooth positioning,which was composed of Bluetooth gateways,Bluetooth beacons,Bluetooth labels and a background data processing platform.The Bluetooth gateway consisted of an active power over ethernet(POE)module,a DC power module,a CPU,a Wi-Fi module and a Bluetooth module;the Bluetooth beacon included a beacon control unit,a Bluetooth transmitter module and a Bluetooth receiver module;the Bluetooth label was made up of a microcontroller unit(MCU),a Bluetooth module,an anti-temper switch and a accelerometer;the data processing platform had the front end developed with Vue architecture and the back end with Java language.Results The system developed could accurately locate the medical equipment in the operating room without electromagnetic interference to other medical devices.Conclusion The system developed gains advantages in high positioning accuracy,low electromagnetic interference,high stability and reliability and low cost,which improves the positioning and management efficiency of medical equipment under the premise of ensuring safety.[Chinese Medical Equipment Journal,2023,44(9):29-32]
4. 基于网络 ? ? 学探讨 ? 脾补肾活血方治疗 缺血性 ? 中的作用机
Meng-Jun LI ; Zhan-Ke QIAO ; Yong-Kang SUN ; Chun-Long RAN ; Chen BAI ; Xiang-Zhe LIU ; Xiao-Yan FANG
Chinese Pharmacological Bulletin 2022;38(4):605-612
Aim To explore the mechanism of Danshen decoction in the treatment of colon cancer using network pharmacology and molecular docking.Methods The active components and corresponding target proteins of Salvia miltiorrhiza, Santalum album and Amo-mum villosum in Danshen decoction were screened based on Traditional Chinese Medicine Systems Pharmacology database and analysis platform.The targets of colon cancer were searched by using Genecards database, and the common targets were selected.The network diagram of traditional Chinese medicine-active components-target-disease was constructed by using Cytoscape 3.7.0.The protein protein interaction network of common targets was constructed by using STRING database.The gene ontology(GO)and Kyoto Encyclopedia of Genes and Gnomes(KEGG)enrichment analysis were carried out based on R4.0.2.The important targets in the key pathways and the important active components in the network diagram of traditional Chinese medicine-active ingredients-target-disease network were selected for Surflex Dock.Results A total of 78 active components, 142 targets, 3 239 colon cancer targets, 105 overlapping targets and 69 corresponding active components were screened out.KEGG analysis showed that the key signaling pathway was PI3K/AKT.Luteolin and Tanshinone IIA with high correlation were selected to dock with protein kinase B(AKT1).Both active components had hydrogen bonding with AKT1.Conclusions Danshen decoction plays a positive role in colon cancer treatment.The mechanism may be related to the regulation of PI3K/AKT signaling pathway.
5.Medicinal chemistry strategies in seeking coronavirus inhibitors
Jing LI ; Xiang-yi JIANG ; Shu-jing XU ; Qing-hua CUI ; Rui-kun DU ; Dong-wei KANG ; Peng ZHAN ; Li-jun RONG ; Xin-yong LIU
Acta Pharmaceutica Sinica 2020;55(4):537-553
The epidemic caused by coronavirus poses a serious threat to human health, but there is no specific drug or vaccine for the treatment of this kind of virus infection. Herein, this article selects typical case studies in recent years and reviews the medicinal chemistry strategies of anti-SARS-CoV, MERS-CoV and other coronavirus drugs from the perspective of medicinal chemistry, and tries to provide some clues to current drug research againstSARS-CoV-2.
6.The progress in the development of HIV inhibitors targeting protein-protein interactions
Zhao WANG ; Desta SAMUEL ; Dong-wei KANG ; Peng ZHAN ; Xin-yong LIU
Acta Pharmaceutica Sinica 2019;54(4):620-628
Protein-protein interaction (PPI) plays an important role in many steps of the human immunodeficiency virus (HIV) life cycle. Targeting these protein-protein interactions, especially the interaction between the virus with host cells, can provide new insights into the development of HIV inhibitors with novel mechanisms of action. Herein, we review the latest discoveries of PPI inhibitors based on the mechanisms of action of various protein-protein interactions with specific research examples.
7.Progress on AIDS drug targets and small molecule inhibitors
Zhi-peng HUO ; Xiao-fang ZUO ; Dong-wei KANG ; Peng ZHAN ; Xin-yong LIU
Acta Pharmaceutica Sinica 2018;53(3):356-374
The difficulty to eradicate the HIV-1, off-target effects together with the rapid emergence of multidrug-resistant strains have created an urgent need for more potent and less toxic therapies against other targets of HIV virus. From the point of view of medicinal chemistry, we summarizes and discusses current endeavours towards the discovery and development of novel inhibitors with various scaffolds or distinct mechanisms of action, and also provides examples illustrating new methodologies in medicinal chemistry that contribute to the identification of novel antiretroviral agents.
8.Progress on HIV-1 RT inhibitors with novel mechanism of action
Zhong-xia ZHOU ; Lin SUN ; Dong-wei KANG ; Zi-hui CHEN ; Miao-miao TANG ; Si-yu LI ; Peng ZHAN ; Xin-yong LIU
Acta Pharmaceutica Sinica 2018;53(5):691-700
HIV-1 reverse transcriptase (RT) plays an important role in HIV-1 life cycle. At present, the listed NRTIs and NNRTIs targeting the RT showed high efficiency as clinical first-line drugs. However, the rapid emergence of multidrug-resistant viruses and significant cumulative drug toxicities compromises antiretroviral therapy efficacy and limits therapeutic options. Therefore, there is an urgent demand for new types of RT inhibitors with novel mechanism of action to address this challenge. In recent years, additional inhibitors with novel mechanism of action have been reported, including nucleic acid competitive inhibitors, reverse transcriptase-directed mutagenesis inhibitors, primers/templates-competitive reverse transcriptase inhibitors, polymerase-RNase H inhibitors, reverse transcription initiation process inhibitors, peptide inhibitors etc., which have brought new hope to the development of novel anti-HIV drugs. This article focuses on the development of these inhibitors.
9.Determination of five effective components in medicinal material of Tripterygium by UPLC-ESI-MS/MS.
Jun HU ; Chao LIU ; Lan-Ping GUO ; Qing-Xiu HAO ; Li-Ping KANG ; Tie-Gui NAN ; Yong LIU ; Zhi-Lai ZHAN ; Lu-Qi HUANG
China Journal of Chinese Materia Medica 2016;41(8):1469-1473
This paper is aimed to develop a method for the determination of five effective components in medicinal material of Tripterygium using ultra performance liquid chromalography coupled with electrospray ionization tandem mass spectrometry(UPLC-ESI-MS/MS), which then was used to study their contents in raw materials from different areas and different sources.The separation was performed on a Waters ACQUITY UPLC-CSH-C18S column(2.1 mm×100 mm,1.7 μm), usingacetonitrile-0.2% ammonium form ateaqueous solutionas mobile phase. The target components were detected in multiple-reaction monitoring(MRM) mode by mass spectrometry with electrospray ionization (ESI) source operated in positive ionization mode. The quantitative results showed that good linearity was achieved in their respective linear ranges and fine determination coefficient (r > 0.997 8),and the overall recoveries ranged from 96.72%-103.2% with the RSD ranging from 1.0%-2.4%.The method is sensitive and accurate, and suitable for the effective components quantification in medicinal material of Tripterygium; contents of five effective components from different sources vary significantly, so the quality and safety of medicinal material of Tripterygium needs to be improved. It is very important to control the quality with multi-index for clinic safety.
10.Study on chemical constituents in Lysinotus wilsonii by UPLC-Q-TOF-MS.
Jun HU ; Quan ZHANG ; Meng-Die QI ; Li-Ping KANG ; Tie-Gui NAN ; Jian YANG ; Yuan YUAN ; Zhi-Lai ZHAN ; Yong LIU ; Lu-Qi HUANG
China Journal of Chinese Materia Medica 2016;41(9):1658-1669
The Ultra-high Performance Liquid Chromatography Quadrupole Time-of-flight Mass Spectrometry(UPLC-Q-TOF-MS)was applied to analyze the chemical components in Lysinotus wilsonii. A Waters ACQUITY UPLC-BEH-C₁₈ S column(2.1 mm×100 mm,1.7 μm)was used with a gradient elution of acetonitrile-water containing 0.1% formic acid. The mass spectrometry equipped with ionization source was used and the data was collected in negative ion mode. Results showed that 57 components were identified as 42 phenylethanoid glycosides, 5 benzyl alcohol glycosides, 6 flavonoids and 4 other components. Among them, 43 compounds were firstly identified in Gensneriaceae and one benzyl alcohol glycoside may be a new compound. We have quite completely identified the components in L. wilsonii for the first time, which may lay the foundation for further study and utilization of the medicinal plant.

Result Analysis
Print
Save
E-mail